The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
103819136 10381913 6 F 20100412 20160830 20140813 20160908 EXP JP-009507513-1112USA03347 MERCK 75.00 YR M Y 0.00000 20160908 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
103819136 10381913 1 PS ISENTRESS RALTEGRAVIR POTASSIUM 1 Oral 800 MG, QD, DIVIDED DOSE FREQUENCY UNKNOWN 22145 800 MG TABLET QD
103819136 10381913 2 SS PREZISTA DARUNAVIR ETHANOLATE 1 Oral 800 MG, QD, 28800 MG 0 800 MG TABLET QD
103819136 10381913 3 SS VALIXA VALGANCICLOVIR 1 Oral 900 MG, BID 43200 MG 0 900 MG TABLET BID
103819136 10381913 4 SS VALIXA VALGANCICLOVIR 1 Oral 900 MG, QD 43200 MG 0 900 MG TABLET QD
103819136 10381913 5 I ADOAIR FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 Respiratory (inhalation) 500 MICROGRAM, BID 0 500 UG INHALATION POWDER BID
103819136 10381913 6 I ADOAIR FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 Respiratory (inhalation) 250 MICROGRAM, BID 0 250 UG INHALATION POWDER BID
103819136 10381913 7 SS TRUVADA EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE 1 Oral 1 DF, QD; DIVIDED DOSE FREQUENCY UNKNOWN 1593 DF Y 0 1 DF TABLET QD
103819136 10381913 8 SS TRUVADA EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE 1 Oral 1 DF, QD; DIVIDED DOSE FREQUENCY UNKNOWN 1593 DF Y 0 1 DF TABLET QD
103819136 10381913 9 SS TRUVADA EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE 1 Oral 1 DF, QD; DIVIDED DOSE FREQUENCY UNKNOWN 1593 DF Y 0 1 DF TABLET QD
103819136 10381913 10 SS TRUVADA EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE 1 Oral 1 DF, QOD 1593 DF Y 0 1 DF TABLET QOD
103819136 10381913 11 I NORVIR RITONAVIR 1 Oral 100 MG, QD; DIVIDED DOSE FREQUENCY UNKNOWN, FORMULATION: POR 3600 MG 0 100 MG QD
103819136 10381913 12 SS NORVIR RITONAVIR 1 Oral 100 MG, QD, DIVIDED DOSE FRQUENCY UNKNOWN 89200 MG 0 100 MG CAPSULE QD
103819136 10381913 13 C EPIVIR LAMIVUDINE 1 Oral 300 MG, QD 150900 MG U 0 300 MG TABLET QD
103819136 10381913 14 C ZERIT STAVUDINE 1 Oral 60 MG; DIVIDED DOSE FREQUENCY UNKNOWN U 0 60 MG CAPSULE QD
103819136 10381913 15 C REYATAZ ATAZANAVIR SULFATE 1 Oral 300 MG, DIVIDED DOSE FREQUENCY UNKNOWN U 0 300 MG CAPSULE QD
103819136 10381913 16 C BAKTAR SULFAMETHOXAZOLETRIMETHOPRIM 1 Oral 1 DF, QD U 0 1 DF TABLET QD
103819136 10381913 17 C DEPAS ETIZOLAM 1 Oral 1 DF, QD U 0 1 DF TABLET QD
103819136 10381913 18 C LYRICA PREGABALIN 1 Oral 75 MG, BID; FORMULATION POR U 0 75 MG BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
103819136 10381913 1 HIV infection
103819136 10381913 2 HIV infection
103819136 10381913 3 Cytomegalovirus infection
103819136 10381913 5 Chronic obstructive pulmonary disease
103819136 10381913 6 Emphysema
103819136 10381913 7 HIV infection
103819136 10381913 11 HIV infection
103819136 10381913 12 HIV infection
103819136 10381913 13 HIV infection
103819136 10381913 14 HIV infection
103819136 10381913 15 HIV infection
103819136 10381913 16 Antifungal prophylaxis
103819136 10381913 17 Insomnia
103819136 10381913 18 Neuralgia

Outcome of event

Event ID CASEID OUTC COD
103819136 10381913 OT
103819136 10381913 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
103819136 10381913 CD4 lymphocytes decreased
103819136 10381913 Cardiac failure
103819136 10381913 Drug interaction
103819136 10381913 Duodenal ulcer
103819136 10381913 Gastrooesophageal reflux disease
103819136 10381913 Glucose tolerance impaired
103819136 10381913 Lymphocyte count decreased
103819136 10381913 White blood cell count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
103819136 10381913 1 20100412 0
103819136 10381913 2 20130426 20130531 0
103819136 10381913 3 20130611 20130701 0
103819136 10381913 4 20130702 20130707 0
103819136 10381913 5 201004 20140807 0
103819136 10381913 6 20140808 0
103819136 10381913 7 20071102 20081113 0
103819136 10381913 8 20100412 20130425 0
103819136 10381913 9 20130601 20131114 0
103819136 10381913 10 20131115 0
103819136 10381913 11 20130426 20130531 0
103819136 10381913 12 20071102 20100411 0
103819136 10381913 13 20081125 20100411 0
103819136 10381913 14 20081125 20100411 0
103819136 10381913 15 20071102 20100411 0
103819136 10381913 17 20130426 0